{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:41:12Z","timestamp":1769071272633,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a recently identified recurrent meningoencephalomyelitis with GFAP immunoglobulin G presence in the serum or cerebrospinal fluid (CSF) as a specific biomarker. GFAP astrocytopathy is closely associated with the occurrence of some tumors and often coexists with other antibodies, such as the N-methyl-D-aspartate receptor and aquaporin-4 antibodies. However, GFAP astrocytopathy complicated by central nervous system infection is rare.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we present the case of a patient admitted to a local hospital due to a prominent fever and cough. The patient had a 1-month history of headaches before admission that were not considered serious at the time. Metagenomic next-generation sequencing (mNGS) of bronchoalveolar lavage fluid revealed a high sequence number of <jats:italic>Legionella pneumophila<\/jats:italic> and a few mycobacteria. His cough and fever improved significantly after antibiotic treatment. Still, a slight headache remained. Subsequently, his condition worsened, and he visited our hospital with a disturbance of consciousness. <jats:italic>Mycobacterium tuberculosis<\/jats:italic> was detected with mNGS of the CSF, while the CSF and serum were also positive for GFAP antibodies. Following anti-tuberculosis and steroid therapy, the patient\u2019s symptoms improved, and he tested negative for the GFAP antibody.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This is the first reported case of GFAP astrocytopathy complicated by tuberculous meningoencephalitis. Due to overlaps in the clinical manifestations of the two diseases, GFAP astrocytopathy is sometimes misdiagnosed as tuberculous meningoencephalitis. Therefore, in addition to ensuring careful identification of the two diseases, clinicians need to be aware of their possible co-existence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03113-w","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T11:03:35Z","timestamp":1676286215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Glial fibrillary acidic protein astrocytopathy and tuberculous meningoencephalitis occurring in a patient with Legionella pneumonia: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Ke","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0073-8868","authenticated-orcid":false,"given":"Yong","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"issue":"11","key":"3113_CR1","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a Novel Meningoencephalomyelitis. JAMA Neurol. 2016;73(11):1297\u2013307.","journal-title":"JAMA Neurol"},{"key":"3113_CR2","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","volume":"9","author":"F Shan","year":"2018","unstructured":"Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol. 2018;9:2802.","journal-title":"Front Immunol"},{"issue":"2","key":"3113_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol. 2017;81(2):298\u2013309.","journal-title":"Ann Neurol"},{"issue":"1","key":"3113_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12883-022-02802-2","volume":"22","author":"J Dang","year":"2022","unstructured":"Dang J, Lei S, Chen J. Autoimmune glial fibrillary acidic protein astrocytopathy presented as isolated area postrema symdrome: a case report. BMC Neurol. 2022;22(1):271.","journal-title":"BMC Neurol"},{"issue":"2","key":"3113_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1055\/s-0042-1742718","volume":"53","author":"C Tan","year":"2022","unstructured":"Tan C, Zhong M, Yao Z, Hong S, Jiang L, Jiang Y. Anti-GFAP Antibody-Associated Hypertrophic Pachymeningitis. Neuropediatrics. 2022;53(2):143\u20135.","journal-title":"Neuropediatrics"},{"issue":"1","key":"3113_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40120-021-00302-y","volume":"11","author":"C H\u00e9raud","year":"2022","unstructured":"H\u00e9raud C, Capet N, Levraut M, Hattenberger R, Bourg V, Thomas P, et al. Glial fibrillary acidic protein (GFAP) astrocytopathy presenting as mild encephalopathy with reversible splenium lesion. Neurol therapy. 2022;11(1):499\u2013505.","journal-title":"Neurol therapy"},{"issue":"3","key":"3113_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ene.13531","volume":"25","author":"Y Long","year":"2018","unstructured":"Long Y, Liang J, Xu H, Huang Q, Yang J, Gao C, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in chinese patients: a retrospective study. Eur J Neurol. 2018;25(3):477\u201383.","journal-title":"Eur J Neurol"},{"key":"3113_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.msard.2018.02.020","volume":"21","author":"J Li","year":"2018","unstructured":"Li J, Xu Y, Ren H, Zhu Y, Peng B, Cui L. Autoimmune GFAP astrocytopathy after viral encephalitis: a case report. Mult Scler Relat Disord. 2018;21:84\u20137.","journal-title":"Mult Scler Relat Disord"},{"key":"3113_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2019.05.010","volume":"98","author":"M Handoko","year":"2019","unstructured":"Handoko M, Hong W, Espineli E, Saxena K, Muscal E, Risen S. Autoimmune glial fibrillary acidic protein astrocytopathy following herpes Simplex Virus Encephalitis in a Pediatric patient. Pediatr Neurol. 2019;98:85\u20136.","journal-title":"Pediatr Neurol"},{"key":"3113_CR10","doi-asserted-by":"publisher","first-page":"950522","DOI":"10.3389\/fimmu.2022.950522","volume":"13","author":"Q He","year":"2022","unstructured":"He Q, Liu J, Zhu Z, Tang Y, Long L, Hu K. Case report: revealing a special and rare autoimmune GFAP astrocytopathy in the spinal cord succeeding neurobrucellosis infection. Front Immunol. 2022;13:950522.","journal-title":"Front Immunol"},{"key":"3113_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroscience.2019.05.018","volume":"410","author":"A Rodr\u00edguez","year":"2019","unstructured":"Rodr\u00edguez A, Delpino M, Miraglia M, Giambartolomei G. Immune Mediators of Pathology in Neurobrucellosis: from blood to Central Nervous System. Neuroscience. 2019;410:264\u201373.","journal-title":"Neuroscience"},{"issue":"10","key":"3113_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/sj.cdd.4400571","volume":"6","author":"S Rutjes","year":"1999","unstructured":"Rutjes S, Utz P, van der Heijden A, Broekhuis C, van Venrooij W, Pruijn G. The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell Death Differ. 1999;6(10):976\u201386.","journal-title":"Cell Death Differ"},{"issue":"3","key":"3113_CR13","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2353\/ajpath.2010.090503","volume":"176","author":"C Garc\u00eda Samartino","year":"2010","unstructured":"Garc\u00eda Samartino C, Delpino M, Pott Godoy C, Di Genaro M, Pasquevich K, Zwerdling A, et al. Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis. Am J Pathol. 2010;176(3):1323\u201338.","journal-title":"Am J Pathol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03113-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03113-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03113-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T23:08:15Z","timestamp":1676329695000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03113-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3113"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03113-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"24 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent to participate was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of identifying images or other personal or clinical details was obtained from the patient. A copy of the written consent is available for review by the Editor of this journal. The authors adhered to the CARE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}